中文 | English
Return
Total: 480 , 1/48
Show Home Prev Next End page: GO
Author:(Yong-xin GUO)

3.Expression and clinical significance of SALL4 expression in gastric carcinoma tissues

Yong GUO ; Yongliang TANG ; Juntao YANG ; Xin ZHANG ; Lei LIU

Chongqing Medicine 2015;(27):3756-3758

4.The collecting and processing system of the sound signal of larynx.

Qing JIAO ; Yong-xin GUO ; Qing-guo MENG ; Xian-yun WANG

Chinese Journal of Medical Instrumentation 2002;26(3):174-176

5.Expression of Inhibitor of Apoptosis Protein Livin in Children with Acute Lymphocytic Leukemia

qun-li, HE ; li-qun, MIAO ; guo-xin, ZHAO ; bin, GUO ; xiang, SUN ; yong-ling, WANG ; guo-qiang, ZHAO

Journal of Applied Clinical Pediatrics 2006;0(15):-

6.Expression of Livin Gene and Its Isoforms in Children with Gliomas

qun-li, HE ; li-qun, MIAO ; guo-xin, ZHAO ; bin, GUO ; xiang, SUN ; yong-ling, WANG ; guo-qiang, ZHAO

Journal of Applied Clinical Pediatrics 2006;0(16):-

7.The monitoring and analysis results of 15 clinical laboratory quality indicators from 2011 to 2015

Chong GUO ; Zijie LIU ; Guibo SONG ; Xin LI ; Xiao WANG ; Yong DUAN

Chinese Journal of Laboratory Medicine 2016;(1):29-33

8.The effects of the compound lavender ointment on experimental guinea pigs scald、anti-inflammation and analgesia

Xin LUO ; Yan SUN ; Xuewei YONG ; Yingfang GUO ; Linlin LI ; Qun ZHANG

Chinese Journal of Comparative Medicine 2014;(9):28-31

9.Clinical efficacy and adverse reactions of body gamma knife in treatment of primary liver cancer

Xuejing XU ; Qian ZHANG ; Mianshun PAN ; Yong LI ; Shujun QIU ; Yutian GUO ; Xin LIU

Journal of Jilin University(Medicine Edition) 2017;43(2):402-407

10.miRNA-101 inhibits the expression of the enhancer of zeste homolog 2 in androgen-independent prostate cancer LNCaP cell line.

Jian-xin LIU ; Qi-fa ZHANG ; Chang-hai TIAN ; Yong ZHANG ; Xiao-zhou HAN ; Hao GUO

National Journal of Andrology 2015;21(6):500-503

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 480 , 1/48 Show Home Prev Next End page: GO